semaglutide for alcohol rebound weight loss was linked to a sharp drop in use in this case report Semaglutide and Tirzepatide reduce alcohol

Triglycerides showed the most dramatic improvement, declining by an average of 14.75 mg/dL

As an obesity specialist pharmacist, I look forward to its eventual approval and the opportunity it will bring to support many more patients who havent yet found the right treatment for them, she said

While its effectiveness in weight loss is impressive, some side effects should be considered: Gastrointestinal Issues: Nausea, vomiting, diarrhea, and constipation are common, especially when starting treatment

It is the first approved dual GIP and GLP-1 receptor agonist, which means it activates two separate incretin pathways that single-agonist medications like semaglutide cannot reach

As consumer demand for prescription GLP-1 weight-management medications continues to expand, telehealth platforms offering physician-supervised treatment options have emerged as a rapidly growing segment of the healthcare market